Naga V Garikipati
St. Luke's-Roosevelt Hospital Center, Wright State University
Papers
2
Total Citations
66
H-Index
2
About
Dr. Naga V. Garikipati is a leading figure in cardiac electrophysiology, best known for pioneering advances in cardiac resynchronization therapy (CRT) for heart failure patients. His research focuses on optimizing lead placement strategies to improve clinical outcomes, particularly for patients who are non-responsive to conventional endovascular approaches. Dr. Garikipati’s seminal 2010 study on robotic epicardial left ventricular lead placement, cited 36 times, established the long-term safety and efficacy of this minimally invasive technique, demonstrating sustained improvements in ventricular function and patient survival. He further advanced the field with his 2013 comparative analysis (30 citations), which systematically evaluated endovascular versus epicardial lead placement, providing critical evidence that robotic epicardial implantation offers a viable and durable alternative for challenging anatomies. By rigorously documenting lead performance and patient outcomes over extended follow-up periods, Dr. Garikipati has helped define best practices for CRT, directly influencing surgical decision-making and expanding therapeutic options for patients with advanced heart failure. His work remains a cornerstone reference for clinicians and researchers seeking to refine device-based therapies.
Research Focus
Key Achievements
Top Papers
- 1
- 2